Nicholas Investment Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-115,187
Closed -$37.4M 195
2023
Q2
$37.4M Sell
115,187
-3,671
-3% -$1.05M 2.56% 4
2023
Q1
$27.8M Buy
118,858
+37,123
+45% +$9.38M 2.11% 11
2022
Q4
$20.6M Buy
81,735
+13,564
+20% +$2.89M 1.8% 9
2022
Q3
$12.1M Buy
68,171
+4,703
+7% +$945K 1.12% 29
2022
Q2
$11.6M Buy
63,468
+6,687
+12% +$1.33M 1.1% 29
2022
Q1
$14.6M Buy
+56,781
New +$13M 1.04% 30
2021
Q3
Sell
-109,746
Closed -$21.2M 195
2021
Q2
$21.2M Buy
109,746
+8,700
+9% +$1.73M 1.33% 18
2021
Q1
$20.9M Sell
101,046
-4,049
-4% -$860K 1.46% 13
2020
Q4
$19.8M Sell
105,095
-1,018
-1% -$166K 1.53% 18
2020
Q3
$13.7M Buy
106,113
+94,057
+780% +$10.4M 1.48% 21
2020
Q2
$1.05M Buy
+12,056
New +$927K 0.21% 139
2020
Q1
Sell
-52,139
Closed -$3.87M 186
2019
Q4
$3.87M Buy
52,139
+23,165
+80% +$1.49M 0.4% 85
2019
Q3
$1.77M Buy
+28,974
New +$1.91M 0.15% 174

Other funds holding INSP

Nicholas Investment Partners's INSP Position: Q3 2023 in Review

Nicholas Investment Partners sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 115,187 shares — an estimated $37.4M sold.

Nicholas Investment Partners first reported a position in INSP in Q3 2019 and held it in 13 quarters. The position peaked at $37.4M in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Nicholas Investment Partners reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Nicholas Investment Partners sold 115,187 Inspire Medical Systems shares in Q3 2023, an estimated $37.4M.
  • Nicholas Investment Partners first reported a position in Inspire Medical Systems in Q3 2019 and held it in 13 quarters.
  • Nicholas Investment Partners's Inspire Medical Systems position peaked at $37.4M in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Nicholas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.